Luminex Partners
Our Partners create powerful, customizable kits for a wide range of industries and specialities while delivering world-class service and support.
There are currently more than 80 Luminex Licensed Technologies Partners that represent a wide diversity of applications, company sizes, geographies, and offerings. We have Partners in fields including life science research, drug as well as vaccine development, clinical diagnostics, agriculture, as well as biodefense applications that range from small companies to multi-national corporations. Our global Partner network provides IVD and RUO kits, reagents, and services.
Featured Partners
Search the bead-based assays that utilize antibody-coated beads to measure and detect analytes of interest, and are ideal for use in an…
R&D Systems, a Bio-Techne brand, offers a variety of Luminex panels that span multiple species and over 450 targets. From the…
MilliporeSigma is a leader in biomarker immunoassays, including >200 MILLIPLEX® multiplex kits with ~1,200 analytes across…
Quantify over 500 different protein and peptide targets simultaneously in a single 12.5 µl sample using the Bio-Plex®…
Find Partners
Results
Zimmer Biomet provides testing services for infectious disease biomarker LDT immunoassays in synovial fluid.
- Application Area: Infectious Disease
- Target: Protein
- Primary Business: Testing Services
- Market Availability: Europe, United States
- Regulatory Classification: RUO
Perform multiple assays with a single sample using ZEUS AtheNA Multi-Lyte® Test Systems for autoimmune and infectious diseases. Paired with the AtheNA Multi-Lyte® Instrument, these multiplex, fluorescent, bead-based test systems offer a simple and efficient alternative to IFA and ELISA testing.
- Application Area: Autoimmune, Infectious Disease
- Target: Protein
- Primary Business: Kits
- Market Availability: Global
- Regulatory Classification: IVD
Through a dedicated focus on test innovation and workflow efficiency, Werfen is helping improve care for patients with autoimmune disease.
- Application Area: Autoimmune, HLA
- Target: Protein, Nucleic Acid
- Primary Business: Kits
- Market Availability: Global
- Regulatory Classification: IVD
Wakunaga Pharmaceutical researches and develops HLA typing reagents and anti-HLA antigen detecting reagents. The HLA typing reagents have been used for the transplantation donor registration in the Japanese bone marrow program and for the platelet donor registration in the Japanese Red Cross Society. In addition, the anti-HLA detecting reagents have been used for testing to determine the PC-HLA supply to patients in the Japanese Red Cross Society.
- Application Area: HLA
- Target: Nucleic Acid, Protein
- Primary Business: Kits
- Market Availability: Asia-Pacific
- Regulatory Classification: IVD
Versiti Blood Center of Wisconsin diagnostic laboratories go beyond a test result, by providing support from their physicians and scientific directors. Their industry-leading, multidisciplinary diagnostic approach provides patient-centric insight in the fields of transfusion medicine, hematology, transplantation, and oncology.
- Target: Nucleic Acid, Protein
- Primary Business: Testing Services
- Market Availability: United States
- Regulatory Classification: RUO
- Application Area: Biomarker Screening, Companion Animal Testing, Infectious Disease
- Target: Protein
- Primary Business: Testing Services
- Market Availability: United States
- Regulatory Classification: RUO
Search the bead-based assays that utilize antibody-coated beads to measure and detect analytes of interest, and are ideal for use in an array of molecular research settings using magnetic, multiplex, singleplex, or custom immunoassays. You can also create custom multiplex RNA or DNA panels for use with the Invitrogen QuantiGene Plex Assay. All of these assays are compatible with all four xMAP® instruments.
- Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Hereditary Diseases, Neurological, Oncology, Vaccines
- Target: Nucleic Acid, Protein
- Primary Business: Kits
- Market Availability: Global
- Regulatory Classification: RUO
The FIDIS™ system, based on xMAP® Technology, offers high-throughput analysis power and allows a simultaneous and specific detection of multiple analytes from the same sample in a single assay. Compared to the conventional IFA or ELISA format, the FIDIS technology and its automation on the Theralis™ platform allows the laboratory to perform analysis more rapidly, and at lower cost, than with conventional kit formats with optimum reliability.
- Application Area: Autoimmune
- Target: Protein
- Primary Business: Kits
- Market Availability: Global
- Regulatory Classification: IVD
Provides Research Use Only kits and testing services of arboviral infections and biothreat agents.
- Target: Protein
- Primary Business: Kits, Testing Services
- Market Availability: Global
- Regulatory Classification: RUO
The Tellgenplex® HPV27 genotyping Assay is a human papillomavirus genotyping DNA detection kit for early screening of cervical cancer and to aid in the diagnosis of genital warts.
- Application Area: Oncology
- Target: Nucleic Acid, Protein
- Primary Business: Kits
- Market Availability: Asia-Pacific
- Regulatory Classification: IVD